327
Views
1
CrossRef citations to date
0
Altmetric
Research Papers

12-Month changes of muscle strength, body composition and physical activity in adults with dystrophinopathies

ORCID Icon, , , , , ORCID Icon, & show all
Pages 1847-1854 | Received 15 Apr 2020, Accepted 06 Aug 2020, Published online: 27 Aug 2020

References

  • Deconinck N, Dan B. Pathophysiology of duchenne muscular dystrophy: current hypotheses. Pediatric Neurology. 2007; 36(1):1–7.
  • Huml RA. Muscular dystrophy: a concise guide. Basingstoke (England): Springer; 2015.
  • Bushby KM, Gardner-Medwin D, Nicholson LV, et al. The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. II. Correlation of phenotype with genetic and protein abnormalities. J Neurol. 1993;240(2):105–112.
  • Hoffman EP, Brown RH, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987;51(6):919–928.
  • Emery AEH. Population frequencies of inherited neuromuscular diseases—a world survey. Neuromuscul. Disord. 1991;1(1):19–29.
  • Emery AEH. The muscular dystrophies. The Lancet. 2002;359(9307):687–695.
  • Bello L, Campadello P, Barp A, et al. Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathies. Sci Rep. 2016;6(1):32439.
  • Ervasti JM, Ohlendieck K, Kahl SD, et al. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature. 1990;345(6273):315–319.
  • Morandi L, Mora M, Gussoni E, et al. Dystrophin analysis in Duchenne and Becker muscular dystrophy carriers: correlation with intracellular calcium and albumin. Ann Neurol. 1990;28(5):674–679.
  • Inkley SR, Oldenburg FC, Vignos PJ. Pulmonary function in Duchenne muscular dystrophy related to stage of disease. Am J Med. 1974;56(3):297–306.
  • Brooke MH, Fenichel GM, Griggs RC, et al. Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology. 1989;39(4):475–475.
  • Bakker JPJ, De Groot IJM, Beelen A, et al. Predictive factors of cessation of ambulation in patients with Duchenne muscular dystrophy. Am J Phys Med Rehabil. 2002;81(12):906–912.
  • Davidson ZE, Truby H. A review of nutrition in Duchenne muscular dystrophy. J Hum Nutr Diet. 2009;22(5):383–393.
  • Jones DA, Round JM, Edwards RH, et al. Size and composition of the calf and quadriceps muscles in Duchenne muscular dystrophy. A tomographic and histochemical study. J Neurol Sci. 1983;60(2):307–322.
  • Kohler M, Clarenbach CF, Böni L, et al. Quality of life, physical disability, and respiratory impairment in Duchenne muscular dystrophy. Am J Respir Crit Care Med. 2005;172(8):1032–1036.
  • Mok E, Letellier G, Cuisset J-M, et al. Assessing change in body composition in children with Duchenne muscular dystrophy: anthropometry and bioelectrical impedance analysis versus dual-energy X-ray absorptiometry. Clinical Nutrition. 2010;29(5):633–638.
  • Henricson E, Abresch R, Han JJ, et al. The 6-minute walk test and person-reported outcomes in boys with duchenne muscular dystrophy and typically developing controls: longitudinal comparisons and clinically-meaningful  changes over one year. PLoS Curr. 2013. DOI:https://doi.org/10.1371/currents.md.9e17658b007eb79fcd6f723089f79e06
  • Bettolo CM, Guglieri M, Eagle M, et al. Adult Duchenne population: a growing population. Neuromusc Disord. 2016;26:S126.
  • Jacques MF, Onambele-Pearson GL, Reeves ND, et al. Relationships between muscle size, strength, and physical activity in adults with muscular dystrophy. J Cachexia Sarcopenia Muscle. 2018;9(6):1042–1052.
  • Akima H, Lott D, Senesac C, et al. Relationships of thigh muscle contractile and non-contractile tissue with function, strength, and age in boys with Duchenne muscular dystrophy. Neuromuscul Disord. 2012;22(1):16–25.
  • Lerario A, Bonfiglio S, Sormani MPia, et al. Quantitative muscle strength assessment in Duchenne muscular dystrophy: longitudinal study and correlation with functional measures. BMC Neurol. 2012;12(1):91.
  • Alfano LN, Lowes LP, Flanigan KM, et al. Correlation of knee strength to functional outcomes in becker muscular dystrophy. Muscle Nerve. 2013;47(4):550–554.
  • Bendixen RM, Lott DJ, Senesac C, et al. Participation in daily life activities and its relationship to strength and functional measures in boys with Duchenne muscular dystrophy. Disabil Rehab. 2014;36(22):1918–1923.
  • Alemdaroğlu I, Karaduman A, Yilmaz ÖT, et al. Different types of upper extremity exercise training in Duchenne muscular dystrophy: effects on functional performance, strength, endurance, and ambulation. Muscle Nerve. 2015;51(5):697–705.
  • Seferian AM, Moraux A, Annoussamy M, et al. Upper limb strength and function changes during a one-year follow-up in non-ambulant patients with Duchenne muscular dystrophy: an observational multicenter trial. PLOS One. 2015;10(2):e0113999.
  • Kilmer DD, Abresch RT, Fowler JWM. Serial manual muscle testing in Duchenne muscular dystrophy. Arch Phys Med Rehabil. 1993;74(11):1168–1171.
  • McDonald CM, Abresch RT, Carter GT, et al. Profiles of neuromuscular diseases: Duchenne muscular dystrophy. Am J Phys Med Rehab. 1995;74(5):S93.
  • McDonald CM, Abresch RT, Carter GT, et al. Profiles of neuromuscular diseases: Becker's muscular dystrophy. American J Phys Med Rehab. 1995;74(5):S104.
  • McDonald CM, Henricson EK, Abresch RT, PTC124-GD-007-DMD Study Group, et al. The 6-minute walk test and other clinical endpoints in Duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study . Muscle Nerve. 2013;48(3):357–368.
  • Batra A, Harrington A, Lott DJ, et al Two-year longitudinal changes in lower limb strength and its relation to loss in function in a large cohort of patients with Duchenne muscular dystrophy. Am J Phys Med Rehab. 2018;97(10):734–740.
  • Wokke BH, van den Bergen JC, Versluis MJ, et al. Quantitative MRI and strength measurements in the assessment of muscle quality in Duchenne muscular dystrophy. Neuromuscul Disord. 2014;24(5):409–416.
  • D’Angelo MG, Berti M, Piccinini L, et al. Gait pattern in Duchenne muscular dystrophy. Gait Posture. 2009;29(1):36–41.
  • Hsu JD, Furumasu J. Gait and posture changes in the Duchenne muscular dystrophy child. Clin Orthop Relat Res. 1993;288:122–125.
  • Mendell JR, Moxley RT, Griggs RC, et al. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med. 1989;320(24):1592–1597.
  • Steffensen BF, Lyager S, Werge B, et al. Physical capacity in non-ambulatory people with Duchenne muscular dystrophy or spinal muscular atrophy: a longitudinal study. Dev Med Child Neurol. 2002;44(9):623–632.
  • Mcdonald CM, Henricson EK, Abresch RT, PTC124-GD-007-DMD Study Group, et al. THE 6‐minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study. Muscle Nerve. 2013;48(3):343–356.
  • Rahbek J, Werge B, Madsen A, et al. Adult life with Duchenne muscular dystrophy: observations among an emerging and unforeseen patient population. Pediatr Rehabil. 2005;8(1):17–28.
  • Palmieri GA, Bertorini TE, Griffin JW, et al. Assessment of whole body composition with dual energy X‐ray absorptiometry in Duchenne muscular dystrophy: correlation of lean body mass with muscle function. Muscle Nerve: Off J Am Assoc Electrodiag Med. 1996;19(6):777–779.
  • Skalsky AJ, Han JJ, Abresch RT, et al. Assessment of regional body composition with dual‐energy X‐ray absorptiometry in Duchenne muscular dystrophy: correlation of regional lean mass and quantitative strength. Muscle Nerve. 2009;39(5):647–651.
  • Beenakker EAC, de Vries J, Fock JM, et al. Quantitative assessment of calf circumference in Duchenne muscular dystrophy patients. Neuromuscul Disord. 2002;12(7–8):639–642.
  • Vohra RS, Lott D, Mathur S, et al. Magnetic resonance assessment of hypertrophic and pseudo-hypertrophic changes in lower leg muscles of boys with duchenne muscular dystrophy and their relationship to functional measurements. PLOS One. 2015;10(6):e0128915.
  • Morse CI, et al. Gastrocnemius medialis muscle architecture and physiological cross sectional area in adult males with Duchenne muscular dystrophy. J Musculoskelet Neuronal Interact. 2015;15(2):154–160.
  • Zanardi MC, Tagliabue A, Orcesi S, et al. Body composition and energy expenditure in Duchenne muscular dystrophy. Eur J Clin Nutr. 2003;57(2):273–278.
  • Bostock EL, Edwards BT, Jacques MF, et al. Impaired glucose tolerance in adults with duchenne and becker muscular dystrophy. Nutrients. 2018;10(12):1947.
  • Jacques MF, Orme P, Smith J, et al. Resting energy expenditure in adults with Becker’s muscular dystrophy. PLOS One. 2017;12(1):e0169848.
  • Hogan SE. Body composition and resting energy expenditure of individuals with Duchenne and Becker muscular dystrophy. Can J Diet Pract Res. 2008;69(4):208–212.
  • World Medical A. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Jama. 2013;310(20):2191.
  • Morse CI, Bostock EL, Twiss HM, et al. The cardiorespiratory response and physiological determinants of the assisted 6-minute handbike cycle test in adult males with muscular dystrophy . Muscle Nerve. 2018;58(3):427–433.
  • McCabe MP, Ricciardelli LA, Parent P. Body mass index. Eating disorders: an encyclopedia of causes. Treat Prevent. 2013;34:90.
  • Williams EA, Read L, Ellis A, et al. The management of equinus deformity in Duchenne muscular dystrophy. J Bone and Joint Surg (British volume). 1984;66-B(4):546–550.
  • Sharma KR, Mynhier MA, Miller RG. Muscular fatigue in Duchenne muscular dystrophy. Neurology. 1995;45(2):306–310.
  • Fukunaga T, Roy RR, Shellock FG, et al. Physiological cross‐sectional area of human leg muscles based on magnetic resonance imaging. J Orthop Res. 1992;10(6):926–934.
  • Reeves ND, Maganaris CN, Narici MV. Ultrasonographic assessment of human skeletal muscle size. Eur J Appl Physiol. 2004;91(1):116–118.
  • Liu M, Chino N, Ishihara T. Muscle damage progression in Duchenne muscular dystrophy evaluated by a new quantitative computed tomography method. Arch Phys Med Rehabil. 1993;74(5):507–514.
  • Løkken N, Hedermann G, Thomsen C, et al. Contractile properties are disrupted in Becker muscular dystrophy, but not in limb girdle type 2I. Ann Neurol. 2016;80(3):466–471.
  • Willcocks RJ, Arpan IA, Forbes SC, et al. Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: effects of age and disease progression. Neuromuscul Disord. 2014;24(5):393–401.
  • Fowler EG, Staudt LA, Heberer KR, et al. Longitudinal community walking activity in Duchenne muscular dystrophy. Muscle Nerve. 2018;57(3):401–406.
  • Dillon CB, Fitzgerald AP, Kearney PM, et al. Number of days required to estimate habitual activity using wrist-worn GENEActiv accelerometer: a cross-sectional study. PLOS One. 2016;11(5):e0109913.
  • Eslinger DW, Rowlands AV, Hurst TL, et al. Validation of the GENEA accelerometer. Med Sci Sports Exer. 2011;43(6):1085–1093.
  • Phillips LRS, Parfitt G, Rowlands AV. Calibration of the GENEA accelerometer for assessment of physical activity intensity in children. J Sci Med Sport. 2013;16(2):124–128.
  • Swinyard CA, Deaver GG, Greenspan L. Gradients of functional ability of importance in rehabilitation of patients with progressive muscular and neuromuscular diseases. Arch Phys Med Rehabil. 1957;38(9):574–579.
  • Melacini P, Vianello A, Villanova C, et al. Cardiac and respiratory involvement in advanced stage Duchenne muscular dystrophy. Neuromusc Disord. 1996;6(5):367–376.
  • Hunsaker RH, Fulkerson PK, Barry FJ, et al. Cardiac function in Duchenne's muscular dystrophy: results of 10-year follow-up study and noninvasive tests. Am J Med. 1982;73(2):235–238.
  • Yamada Y, Kawakami M, Wada A, et al. Long-term follow-up of dysphagia in adult patients with Duchenne muscular dystrophy. Eur J Paediat Neurol. 2018;22(5):786–790.
  • Hogrel J-Y, Payan CA, Ollivier G, et al. Development of a French isometric strength normative database for adults using quantitative muscle testing. Arch Phys Med Rehabil. 2007;88(10):1289–1297.
  • Cuthbert SC, Goodheart GJ. On the reliability and validity of manual muscle testing: a literature review. Chiropr Osteopat. 2007;15:4.
  • Lue Y-J, Lin R-F, Chen S-S, et al. Measurement of the functional status of patients with different types of muscular dystrophy. Kaohsiung J Med Sci. 2009;25(6):325–333.
  • Pane M, Vasta I, Messina S, et al. Feeding problems and weight gain in Duchenne muscular dystrophy. Eur J Paediatr Neurol. 2006;10(5–6):231–236.
  • Ferguson MR, Poliachik SL, Shaffer ML, et al. Quantitative MRI reveals decelerated fatty infiltration in muscles of active FSHD patients. Neurology. 2016;87(16):1746–1746.
  • Phillips M, Flemming N, Tsintzas K. An exploratory study of physical activity and perceived barriers to exercise in ambulant people with neuromuscular disease compared with unaffected controls. Clin Rehabil. 2009;23(8):746–755.
  • Pane M, Mazzone ES, Sivo S, et al. Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changes. PLOS One. 2014;9(10):e108205.
  • Pane M, Mazzone ES, Sormani MP, et al. 6 Minute walk test in Duchenne MD patients with different mutations: 12 month changes. PLOS One. 2014;9(1):e83400.
  • Mazzone E, Vasco G, Sormani MP, et al. Functional changes in Duchenne muscular dystrophy a 12-month longitudinal cohort study. Neurology. 2011;77(3):250–256.
  • Bonati U, Hafner P, Schädelin S, et al. Quantitative muscle MRI: a powerful surrogate outcome measure in Duchenne muscular dystrophy. Neuromuscular Disorders. 2015;25(9):679–685.
  • Janssen B, Voet N, Geurts A, et al. Quantitative MRI reveals decelerated fatty infiltration in muscles of active FSHD patients. Neurology. 2016;86(18):1700–1707.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.